Literature DB >> 70209

Combined effects of bleomycin and X-rays on DNA synthesis in asynchronous Ehrlich ascites cells in suspension.

F A Alalawi, I V Chapman.   

Abstract

Separate and combined effects of bleomycin and X-rays on rates of uptake of [14C]thymidine into Ehrlich ascites cells were assessed for extracellular drug concentrations of 12 micron (20 microgram/ml) and radiation doses of 2-5 krad. Rates of DNA synthesis were followed by monitoring the activity of the acid-insoluble portion of the asynchronous culture. The 14C activity of the acid-soluble pool was assessed in determining the rate of passage of 14C-TdR across the cell membrane. The results reveal that whilst the effects of each agent on TdR uptake rates are markedly different, they both inhibit DNA synthesis. Combined studies with both agents, 2-5 krad X-rays plus 20 microgram/ml bleomycin before, simultaneously or after exposure to X-rays, produced additive or less than additive effects on rates of incorporation of TdR into DNA. However, when the drug dose is split 2 X 10 microgram/ml before and after exposure to 2-5 krad X-rays, a synergistic effect on inhibition of DNA synthesis is observed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70209      PMCID: PMC2025433          DOI: 10.1038/bjc.1977.157

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Studies on the mechanism of antitumor effect of bleomycin of squamous cell carcinoma.

Authors:  H Umezawa; T Takeuchi; S Hori; T Sawa; M Ishizuka
Journal:  J Antibiot (Tokyo)       Date:  1972-07       Impact factor: 2.649

2.  Time-dose relationships in combined bleomycin treatment and radiotherapy.

Authors:  S J Jorgensen
Journal:  Eur J Cancer       Date:  1972-10       Impact factor: 9.162

3.  Nucleic acid--specificity of bleomycin.

Authors:  C W Haidle; M T Kuo; K K Weiss
Journal:  Biochem Pharmacol       Date:  1972-12-15       Impact factor: 5.858

4.  Radiosensitization of bleomycin on lethal effect of mouse cancer cell in vitro.

Authors:  T Matsuzawa; M Onozawa; K Morita; M Kakehi
Journal:  Strahlentherapie       Date:  1972-11

5.  Release of free bases from deoxyribonucleic acid after reaction with bleomycin.

Authors:  C W Haidle; K K Weiss; M T Kuo
Journal:  Mol Pharmacol       Date:  1972-09       Impact factor: 4.436

6.  Strand-scission of HeLa cell deoxyribonucleic acid by bleomycin in vitro and in vivo.

Authors:  Y Fujiwara; T Kondo
Journal:  Biochem Pharmacol       Date:  1973-02-01       Impact factor: 5.858

7.  Bleomycin in advanced squamous-cell carcinoma of head and neck.

Authors:  P Grey; L Michaels
Journal:  Med J Aust       Date:  1972-07-29       Impact factor: 7.738

8.  Inhibition of ligase reaction by bleomycin.

Authors:  M Miyaki; T Ono; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1971-09       Impact factor: 2.649

9.  New antibiotics, bleomycin A and B.

Authors:  H Umezawa; K Maeda; T Takeuchi; Y Okami
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

10.  Early clinical experience with bleomycin in the United Kingdom in series of 105 patients.

Authors:  K E Halnan; N M Bleehen; T B Brewin; T J Deeley; D F Harrison; C Howland; P B Kunkler; G L Ritchie; E Wiltshaw; I D Todd
Journal:  Br Med J       Date:  1972-12-16
View more
  2 in total

1.  Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer predisposition.

Authors:  I Vorechovsky; M Munzarova; J Lokaj
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Increased breakage of chromosome 1 in lymphocytes of patients with testicular cancer after bleomycin treatment in vitro.

Authors:  I Vorechovsky; J Zaloudik
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.